Cargando…

Disaggregation Following Agonist-Induced Platelet Activation in Patients on Dual Antiplatelet Therapy

Disaggregation as the difference between maximal and final platelet aggregation by light transmission aggregometry indicates the stability of platelet aggregates. We evaluated the extent of disaggregation after platelet stimulation with adenosine diphosphate (ADP), arachidonic acid (AA), collagen, e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wadowski, Patricia P., Eichelberger, Beate, Kopp, Christoph W., Pultar, Joseph, Seidinger, Daniela, Koppensteiner, Renate, Lang, Irene M., Panzer, Simon, Gremmel, Thomas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer US 2017
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5585279/ https://www.ncbi.nlm.nih.gov/pubmed/28425039 http://dx.doi.org/10.1007/s12265-017-9746-0

Ejemplares similares

Ticagrelor Inhibits Toll-Like and Protease-Activated Receptor Mediated Platelet Activation in Acute Coronary Syndromes
por: Wadowski, Patricia P., et al.
Publicado: (2020)

Protease‐activated receptor‐mediated platelet aggregation in acute coronary syndrome patients on potent P2Y(12) inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Comparison of Aggregometry with Flow Cytometry for the Assessment of Agonists´-Induced Platelet Reactivity in Patients on Dual Antiplatelet Therapy
por: Gremmel, Thomas, et al.
Publicado: (2015)

Comparison of Light Transmission Aggregometry With Impedance Aggregometry in Patients on Potent P2Y12 Inhibitors
por: Wadowski, Patricia P., et al.
Publicado: (2020)

Interleukin-6 and Asymmetric Dimethylarginine Are Associated with Platelet Activation after Percutaneous Angioplasty with Stent Implantation
por: Gremmel, Thomas, et al.
Publicado: (2015)

Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Acute Coronary Syndrome: Implications for Platelet Reactivity?
por: Tscharre, Maximilian, et al.
Publicado: (2020)

Growth Differentiation Factor 15 Is Associated with Platelet Reactivity in Patients with Acute Coronary Syndrome
por: Mutschlechner, David, et al.
Publicado: (2023)

Decreased Platelet Inhibition by Thienopyridines in Hyperuricemia
por: Lee, Silvia, et al.
Publicado: (2020)

Microvascular Thrombosis as a Critical Factor in Severe COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2023)

Toll-like Receptors as Pro-Thrombotic Drivers in Viral Infections: A Narrative Review
por: Panzer, Benjamin, et al.
Publicado: (2023)

Glycocalyx as Possible Limiting Factor in COVID-19
por: Wadowski, Patricia P., et al.
Publicado: (2021)

Platelet-to-lymphocyte and Neutrophil-to-lymphocyte Ratios Predict Target Vessel Restenosis after Infrainguinal Angioplasty with Stent Implantation
por: Lee, Silvia, et al.
Publicado: (2020)

Plasma Levels of snoRNAs are Associated with Platelet Activation in Patients with Peripheral Artery Disease
por: Nossent, Anne Yaël, et al.
Publicado: (2019)

Growth Differentiation Factor-15 Correlates Inversely with Protease-Activated Receptor-1-Mediated Platelet Reactivity in Patients with Left Ventricular Assist Devices
por: Tscharre, Maximilian, et al.
Publicado: (2022)

Protease‐activated receptor‐mediated platelet aggregation in patients with type 2 diabetes on potent P2Y (12) inhibitors
por: Panzer, Benjamin, et al.
Publicado: (2022)

Functional capillary impairment in patients with ventricular assist devices
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Association of Soluble Suppression of Tumorigenesis 2 (sST2) With Platelet Activation, Monocyte Tissue Factor and Ischemic Outcomes Following Angioplasty and Stenting
por: Stojkovic, Stefan, et al.
Publicado: (2020)

Micro- and Macrovascular Effects of Inflammation in Peripheral Artery Disease—Pathophysiology and Translational Therapeutic Approaches
por: Poledniczek, Michael, et al.
Publicado: (2023)

α-Hydroxybutyrate dehydrogenase is associated with atherothrombotic events following infrainguinal angioplasty and stenting
por: Lee, Silvia, et al.
Publicado: (2019)

Platelet reactivity patterns in patients treated with dual antiplatelet therapy
por: Winter, Max‐Paul, et al.
Publicado: (2019)

Acute Limb Ischemia after Intake of the Phenylethylamine Derivate NBOMe
por: Wadowski, Patricia P., et al.
Publicado: (2019)

Short dual antiplatelet therapy and dual antiplatelet therapy de-escalation after primary percutaneous intervention: For whom and how
por: Muthspiel, Marie, et al.
Publicado: (2022)

Platelet aggregometry assay for evaluating the effects of platelet agonists and antiplatelet compounds on platelet function in vitro
por: Tsoupras, Alexandros, et al.
Publicado: (2018)

Surrogate Markers of Neutrophil Extracellular Trap Formation are Associated with Ischemic Outcomes and Platelet Activation after Peripheral Angioplasty and Stenting
por: Demyanets, Svitlana, et al.
Publicado: (2020)

Impaired glucose metabolism is associated with increased thrombin generation potential in patients undergoing angioplasty and stenting
por: Lee, Silvia, et al.
Publicado: (2018)

Novel aspects of antiplatelet therapy in cardiovascular disease
por: Gremmel, Thomas, et al.
Publicado: (2018)

Effects of colchicine on platelet aggregation in patients on dual antiplatelet therapy with aspirin and clopidogrel
por: Cirillo, Plinio, et al.
Publicado: (2020)

Inpatient prescribing of dual antiplatelet therapy according to the guidelines: a prospective intervention study
por: Moerlie, Ashwin R., et al.
Publicado: (2020)

Platelets: Pathophysiology and Antiplatelet Drug Therapy
por: Snyder, Edward L.
Publicado: (1983)

Clinically relevant exaggerated pharmacodynamic response to dual antiplatelet therapy detected by Thromboelastogram(®) Platelet Mapping™
por: Hiller, Kenneth N.
Publicado: (2016)

Impact of Diabetes on Platelet Function in Acute Ischemic Stroke Patients Taking Dual Antiplatelet Therapy
por: Guo, Yinping, et al.
Publicado: (2021)

A Case of Autoimmune Small Fiber Neuropathy as Possible Post COVID Sequelae
por: Panagiotides, Noel G., et al.
Publicado: (2023)

Dual Antiplatelet Therapy (DAPT) versus No Antiplatelet Therapy and Incidence of Major Bleeding in Patients on Venoarterial Extracorporeal Membrane Oxygenation
por: Staudacher, Dawid L., et al.
Publicado: (2016)

Platelet Reactivity in Hepatitis C Virus–Infected Patients on Dual Antiplatelet Therapy for Acute Coronary Syndrome
por: Scudiero, Fernando, et al.
Publicado: (2020)

Being Overweight or Obese Is Associated with an Increased Platelet Reactivity Despite Dual Antiplatelet Therapy with Aspirin and Clopidogrel
por: Puccini, Marianna, et al.
Publicado: (2022)

Platelet Function Testing-Guided Antiplatelet Therapy
por: Lenk, Ekaterina, et al.
Publicado: (2014)

Molecular mechanisms of amyloid disaggregation
por: Low, Kimberly Jia Yi, et al.
Publicado: (2021)

Neural Fourier Energy Disaggregation
por: Nalmpantis, Christoforos, et al.
Publicado: (2022)

Factors associated with platelet reactivity during dual antiplatelet therapy in patients with diabetes after acute coronary syndrome
por: Tatarunas, Vacis, et al.
Publicado: (2020)

Cardiovascular Disease Management in the Context of Global Crisis
por: Wadowski, Patricia P., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_mmpbtkvb451hfpbvpcvuue2oau